Global Human Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Human Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Human Rabies Vaccine market size was valued at US$ 1137 million in 2024 and is forecast to a readjusted size of USD 1512 million by 2031 with a CAGR of 4.2% during review period.

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

The increasing awareness of rabies prevention and the rising number of reported cases of animal bites, particularly in developing countries, are key drivers of the human rabies vaccine market. Government-led vaccination programs, international health initiatives, and educational campaigns have significantly boosted demand for pre- and post-exposure prophylaxis, including human rabies vaccines. Moreover, improvements in vaccine technology, such as the development of safer and more effective vaccines, are also contributing to the growth of the market.

One major challenge in the human rabies vaccine market is the uneven access to vaccines, especially in regions where rabies is endemic. High costs, cold chain requirements for storage, and distribution challenges in rural or underdeveloped areas make it difficult for healthcare providers to ensure timely vaccination. Additionally, a lack of healthcare infrastructure and trained personnel to administer the vaccine can hinder its effectiveness in regions most affected by rabies, limiting the overall impact of vaccination efforts.

Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share. Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

This report is a detailed and comprehensive analysis for global Human Rabies Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Human Rabies Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Human Rabies Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Human Rabies Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Human Rabies Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Human Rabies Vaccine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Human Rabies Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Human Rabies Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others

Market segment by Application
Pre-Exposure Vaccine
Post-Exposure Vaccine

Major players covered
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Human Rabies Vaccine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Human Rabies Vaccine, with price, sales quantity, revenue, and global market share of Human Rabies Vaccine from 2020 to 2025.

Chapter 3, the Human Rabies Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Human Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Rabies Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Human Rabies Vaccine.

Chapter 14 and 15, to describe Human Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.